Browsing Tag
Oragenics Inc
1 post
The $9bn concussion treatment question Oragenics hopes ONP-002 can answer
Oragenics launches Phase IIa trial of ONP-002 for concussion. Discover whether this therapy could unlock the $9B traumatic brain injury market.